Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-03-21 | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P.
(Sr. VP of IP, CSO) |
S | Common Stock | D | 14491 | $35.31 - $35.31 | $511,677 |
2024-03-21 | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P.
(Sr. VP of IP, CSO) |
M | Common Stock | A | 14491 | $25.30 - $25.30 | $366,622 |
2024-03-19 | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P.
(Sr. VP of IP, CSO) |
S | Common Stock | D | 12364 | $35.31 - $35.31 | $436,572 |
2024-03-19 | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P.
(Sr. VP of IP, CSO) |
M | Common Stock | A | 12364 | $25.30 - $25.30 | $312,809 |
2024-03-13 | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P.
(Sr. VP of IP, CSO) |
S | Common Stock | D | 62366 | $33.48 - $34.10 | $2,104,288 |
2024-03-13 | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P.
(Sr. VP of IP, CSO) |
M | Common Stock | A | 62366 | $12.98 - $23.99 | $1,098,522 |
2024-02-22 | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan
(SVP, Chief Medical Officer) |
F | Common Stock | D | 303 | $27.94 - $27.94 | $8,465 |
2024-02-22 | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan
(SVP, Chief Medical Officer) |
A | Common Stock | A | 750 | $0.00 - $0.00 | $0 |
2024-02-22 | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P.
(Sr. VP of IP, CSO) |
F | Common Stock | D | 372 | $27.94 - $27.94 | $10,393 |
2024-02-22 | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P.
(Sr. VP of IP, CSO) |
A | Common Stock | A | 750 | $0.00 - $0.00 | $0 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |